1.  

Article types	Other
Language	English
Refereed paper	Not refereed
Title	Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
Journal	Formal name：Hepatology research : the official journal of the Japan Society of Hepatology ISSN code：13866346
Domestic / Foregin	Foregin
Volume, Number, Page	53(5),pp.383-390
Papers・Author	Hasegawa Kiyoshi, Takemura Nobuyuki, Yamashita Tatsuya, Watadani Takeyuki, Kaibori Masaki, Kubo Shoji, Shimada Mitsuo, Nagano Hiroaki, Hatano Etsuro , Aikata Hiroshi, Iijima Hiroko , Ueshima Kazuomi , Ohkawa Kazuyoshi, Genda Takuya, Tsuchiya Kaoru, Torimura Takuji, Ikeda Masafumi, Furuse Junji, Akahane Masaaki, Kobayashi Satoshi, Sakurai Hideyuki, Takeda Atsuya, Murakami Takamichi, Motosugi Utaroh, Matsuyama Yutaka, Kudo Masatoshi, Tateishi Ryosuke, The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan
Publication date	2023/05
Papers・Description	The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2021 in Japanese. In addition to surveillance-diagnostic and treatment algorithms, a new algorithm for systemic therapy has been created, as multiple drugs for hepatocellular carcinoma can be currently selected. Here, new or revised algorithms and evidence on which the recommendations are based are described.